FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380078081> ?p ?o ?g. }

• W4380078081 abstract "Emblica officinalis (EO) fruit consumption has been found to have a beneficial effect on cardiovascular disease (CVD) physiological risk factors in preliminary clinical intervention trials; however, questions remain regarding the overall effectiveness of EO on CVD risk. The purpose of this systematic review and meta-analysis is to: 1) systematically describe the clinical research examining EO; and 2) quantitatively assess the effects of EO on CVD physiological risk factors.The Pubmed, Embase, Web of Science, and Google Scholar electronic platforms were searched for relevant randomized controlled trials (RCTs) published until April 7, 2021. Studies were included if they involved adults (age ≥ 18 years) ingesting a form of EO fruit; included blood lipids, blood pressure, and/or inflammatory biomarkers as outcomes; had clearly defined intervention and control treatments with pre- and post-intervention data; were peer-reviewed; and were written in English. Studies were excluded if they compared EO with another risk reduction intervention without a usual care control group. RCTs were assessed for methodological quality using the Cochrane risk-of-bias version 2 (ROB2) tool, qualitatively described, and quantitatively evaluated using random and fixed effect meta-analysis models.A total of nine RCTs (n = 535 participants) were included for review. Included studies followed parallel-group (n = 6) and crossover (n = 3) designs, with EO dosage ranging from 500 mg/day to 1500 mg/day, and treatment duration ranging from 14 to 84 days. Meta-analyses revealed EO to have a significant composite effect at lowering low-density lipoprotein cholesterol (LDL-C; Mean difference (MD) = -15.08 mg/dL [95% Confidence interval (CI) = -25.43 to -4.73], I2 = 77%, prediction interval = -48.29 to 18.13), very low-density lipoprotein cholesterol (VLDL-C; MD = -5.43 mg/dL [95% CI = -8.37 to -2.49], I2 = 44%), triglycerides (TG; MD = -22.35 mg/dL [95% CI = -39.71 to -4.99], I2 = 62%, prediction interval = -73.47 to 28.77), and high-sensitivity C-reactive protein (hsCRP; MD = -1.70 mg/L [95% CI = -2.06 to -1.33], I2 = 0%) compared with placebo.Due to statistical and clinical heterogeneity in the limited number of clinical trials to date, the promising effects of EO on physiologic CVD risk factors in this review should be interpreted with caution. Further research is needed to determine if EO offers an efficacious option for primary or secondary prevention of CVD as either monotherapy or adjunct to evidence-based dietary patterns and/or standard pharmacotherapy." @default.
• W4380078081 created "2023-06-10" @default.
• W4380078081 creator A5009615726 @default.
• W4380078081 creator A5067520533 @default.
• W4380078081 creator A5068637615 @default.
• W4380078081 creator A5074762744 @default.
• W4380078081 date "2023-06-09" @default.
• W4380078081 modified "2023-10-10" @default.
• W4380078081 title "Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis" @default.
• W4380078081 cites W1229597027 @default.
• W4380078081 cites W1965018701 @default.
• W4380078081 cites W1983865577 @default.
• W4380078081 cites W1986920833 @default.
• W4380078081 cites W1998908291 @default.
• W4380078081 cites W1999492038 @default.
• W4380078081 cites W2000142287 @default.
• W4380078081 cites W2001525742 @default.
• W4380078081 cites W2011088609 @default.
• W4380078081 cites W2017602185 @default.
• W4380078081 cites W2021672120 @default.
• W4380078081 cites W2024096565 @default.
• W4380078081 cites W2042847734 @default.
• W4380078081 cites W2054052622 @default.
• W4380078081 cites W2060692557 @default.
• W4380078081 cites W2063910199 @default.
• W4380078081 cites W2077956743 @default.
• W4380078081 cites W2083857599 @default.
• W4380078081 cites W2087496615 @default.
• W4380078081 cites W2092342052 @default.
• W4380078081 cites W2098574146 @default.
• W4380078081 cites W2116404316 @default.
• W4380078081 cites W2121898880 @default.
• W4380078081 cites W2126930838 @default.
• W4380078081 cites W2129448542 @default.
• W4380078081 cites W2130235475 @default.
• W4380078081 cites W2155042083 @default.
• W4380078081 cites W2157699400 @default.
• W4380078081 cites W2163541103 @default.
• W4380078081 cites W2164443473 @default.
• W4380078081 cites W2222677470 @default.
• W4380078081 cites W2325016058 @default.
• W4380078081 cites W2326178392 @default.
• W4380078081 cites W2438662741 @default.
• W4380078081 cites W2460932612 @default.
• W4380078081 cites W2473379350 @default.
• W4380078081 cites W2485118186 @default.
• W4380078081 cites W2514394534 @default.
• W4380078081 cites W2544993155 @default.
• W4380078081 cites W2570555403 @default.
• W4380078081 cites W2581664974 @default.
• W4380078081 cites W2737716318 @default.
• W4380078081 cites W2774587119 @default.
• W4380078081 cites W2804293659 @default.
• W4380078081 cites W2897227944 @default.
• W4380078081 cites W2916699521 @default.
• W4380078081 cites W2947625079 @default.
• W4380078081 cites W2970684805 @default.
• W4380078081 cites W2989599752 @default.
• W4380078081 cites W3003299879 @default.
• W4380078081 cites W3008184487 @default.
• W4380078081 cites W3018517209 @default.
• W4380078081 cites W3019350884 @default.
• W4380078081 cites W3092293792 @default.
• W4380078081 cites W3118615836 @default.
• W4380078081 cites W3126476985 @default.
• W4380078081 cites W4211103390 @default.
• W4380078081 doi "https://doi.org/10.1186/s12906-023-03997-8" @default.
• W4380078081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37296402" @default.
• W4380078081 hasPublicationYear "2023" @default.
• W4380078081 type Work @default.
• W4380078081 citedByCount "0" @default.
• W4380078081 crossrefType "journal-article" @default.
• W4380078081 hasAuthorship W4380078081A5009615726 @default.
• W4380078081 hasAuthorship W4380078081A5067520533 @default.
• W4380078081 hasAuthorship W4380078081A5068637615 @default.
• W4380078081 hasAuthorship W4380078081A5074762744 @default.
• W4380078081 hasBestOaLocation W43800780811 @default.
• W4380078081 hasConcept C126322002 @default.
• W4380078081 hasConcept C168563851 @default.
• W4380078081 hasConcept C17744445 @default.
• W4380078081 hasConcept C1862650 @default.
• W4380078081 hasConcept C189708586 @default.
• W4380078081 hasConcept C199539241 @default.
• W4380078081 hasConcept C2778163477 @default.
• W4380078081 hasConcept C2778270857 @default.
• W4380078081 hasConcept C2779134260 @default.
• W4380078081 hasConcept C2779473830 @default.
• W4380078081 hasConcept C3017536533 @default.
• W4380078081 hasConcept C44249647 @default.
• W4380078081 hasConcept C556039675 @default.
• W4380078081 hasConcept C71924100 @default.
• W4380078081 hasConcept C82789193 @default.
• W4380078081 hasConcept C84393581 @default.
• W4380078081 hasConcept C95190672 @default.
• W4380078081 hasConceptScore W4380078081C126322002 @default.
• W4380078081 hasConceptScore W4380078081C168563851 @default.
• W4380078081 hasConceptScore W4380078081C17744445 @default.
• W4380078081 hasConceptScore W4380078081C1862650 @default.
• W4380078081 hasConceptScore W4380078081C189708586 @default.
• W4380078081 hasConceptScore W4380078081C199539241 @default.

• next